FDA Enforcement Class I Terminated

NeuRx Diaphragm Pacing System (NeuRx DPS) External Pulse Generator (EPG), Part No. 23-0021.

Recall: Z-1561-2022 · Reported August 31, 2022

Enforcement

Recall Number
Z-1561-2022
Event ID
90626
Classification
Class I
Status
Terminated
Product Type
Devices
Firm
Synapse Biomedical Inc
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
E-Mail
Report Date
August 31, 2022
Initiation Date
July 11, 2022
Classification Date
August 22, 2022
Termination Date
October 24, 2023
Address
300 Artino St, Oberlin, OH, 44074-1263, United States

Description

NeuRx Diaphragm Pacing System (NeuRx DPS) External Pulse Generator (EPG), Part No. 23-0021.

Reason

Due to a defect identified on the EPG controller printed circuit board assembly, device performance may degrade over time. Depending on the failure mode, potential adverse events include pain, muscle fatigue and decreased breathing effectiveness, arrhythmia or cardiac arrest, or the device may stop unexpectedly.

Code Info

UDI-DI: 00852184003212; Serial Nos. 1900 thru 2017

Distribution

distribution to US states of AL, CO, IL, FL, GA, MD, MN, NC, NJ, OH, PA, and SC; Germany and Kuwait. ***Updated 3/28/23 - Product was not distributed to United Arab Emirates. Product was distributed to Kuwait.*** Updated 9.14.23 - 1 patient in Germany, 1 patient in the Czech Republic, 1 distributor in Kuwait

Quantity

118 (112 US, 6 OUS)